Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Stable overexpression of MED19 in androgen-dependent LNCaP cells promotes growth under conditions of androgen deprivation
PubMed Full text in PMC Similar studies
Transcriptome profiles of alternative MED19 LNCaP and control LNCaP cells cultured under androgen deprivation with vehicle or R1881
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Genome-wide maps of the androgen receptor and H3K27 upon MED19 overexpression in LNCaP cells
PubMed Full text in PMC Similar studies SRA Run Selector
Transcriptome profiles of canonical MED19 LNCaP and control LNCaP cells cultured under androgen deprivation with vehicle or R1881 treatment
PubMed Full text in PMC Similar studies Analyze with GEO2R
Elk1 Directs a Critical Component of Growth Signaling by the Androgen Receptor in Prostate Cancer
HIPK2 and MED19 are new regulators of androgen receptor in prostate cancer cells
Genome-wide impact of ART-27 loss on androgen-regulated transcription in prostate cancer cells
A Novel Androgen Receptor Splice Variant Is Upregulated during Prostate Cancer Progression
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation.
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [RNA-seq]
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [ChIP-seq]
Hormone-Independence of Prostate Cancer Cells is Supported by the Androgen Receptor without Binding to Classical Response Elements
Late passage LNCaP prostate tumor cells treated with androgen receptor shRNA or androgen R1881
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
The DNA/RNA helicase DHX9 contributes to the transcriptional program of Androgen Receptor in prostate cancer.
LincRNA PVT1 associates with EZH2 and with the androgen receptor in LNCaP prostate cancer cells and inhibits the expression of genes involved with cell death, cell differentiation and cell adhesion
Total RNA-Seq in control and TRAF4-overexpressing LNCaP cells
Total RNA-Seq in TRAF4-overexpressing castration-resistant xenograft tumors and the control castration-responsive tumors
Genome-wide AR binding under androgen deprivation condition upon TRAF4 overexpression
LNCaP prostate cancer cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on